Close

Revogene® Carba C

The Revogene Carba C assay provides healthcare systems with a diagnostic solution to enable early detection and management of Carbapenem-Resistant Enterobacterales (CRE) from isolated colonies of Enterobacteriaceae, Acinetobacter baumannii, or Pseudomonas aeruginosa.

Catalog Number: 410500

Why Revogene Carba C?

Carbapenem-Resistant Enterobacterales (CRE) infections are hazardous to our patients and alarming for healthcare systems. The CDC has deemed CRE an urgent public health threat that requires immediate and aggressive action. 1

Early identification and isolation of colonized or infected patients is key to limiting the spread of these organisms in healthcare settings and to help in better guidance of treatment.

1. https://www.cdc.gov/drugresistance/biggest_threats.html


  • sample_result_icon

    Efficient workflow - Sample to result in 3 easy steps

  • assay_flexibility_icon

    Flexible platform - Run multiple assays with different sample types on a single run

  • expansion_icon

    Platform for growth - Single analyte and multiplex testing capability

  • tech_icon2

    Total solution - Can be paired with Meridian immunoassays for a scalable testing solution

Related Tests

btn play

Early detection is key for CRE infection prevention and control. The CDC recommends “detecting and protecting” through early identification of CRE carriers, followed by prevention of transmission through implementation of infection control precautions.

CDC recommends “detecting and protecting"

Definitive answers, confidence in results

Contact Sales

Definitive answers, confidence in results

Contact Sales

Support & Documents

Downloadable PDFs

FAQs

Revogene Carba C – 87150 x 5

1. https://www.cdc.gov/drugresistance/biggest_threats.html

2. https://www.cdc.gov/hai/organisms/cre/index.html

3. https://www.cdc.gov/hai/organisms/cre/cre-clinicianfaq.html

4. Neuner, E. & Gallagher J., 2017. Pharmacodynamic and pharmacokinetic considerations in the treatment of critically ill patients infected with carbapenem-resistant Enterobacteriaceae. Virulence. 8(4):440-452.

Pricing

To order, Contact your regional sales representative or use the following contact information:

Contact Sales
Rectangle

Get In Touch With Us

Contact Us
Welcome to
logo blue

Please select your country to continue

Continue
CN